Renal Cancers Active Not Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02964078Interleukin-2 and Pembrolizumab for Metastatic Kidney CancerTreatment